首页> 外文期刊>Transboundary and emerging diseases >An inter-laboratory comparative study of serological tools employed in the diagnosis of Besnoitia besnoiti infection in bovines.
【24h】

An inter-laboratory comparative study of serological tools employed in the diagnosis of Besnoitia besnoiti infection in bovines.

机译:牛血清贝氏疟原虫感染诊断中使用的血清学工具的实验室间比较研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Bovine besnoitiosis is considered an emerging chronic and debilitating disease in Europe. Many infections remain subclinical, and the only sign of disease is the presence of parasitic cysts in the sclera and conjunctiva. Serological tests are useful for detecting asymptomatic cattle/sub-clinical infections for control purposes, as there are no effective drugs or vaccines. For this purpose, diagnostic tools need to be further standardized. Thus, the aim of this study was to compare the serological tests available in Europe in a multi-centred study. A coded panel of 241 well-characterized sera from infected and non-infected bovines was provided by all participants (SALUVET-Madrid, FLI-Wusterhausen, ENV-Toulouse, IPB-Berne). The tests evaluated were as follows: an in-house ELISA, three commercial ELISAs (INGEZIM BES 12.BES.K1 INGENASA, PrioCHECK Besnoitia Ab V2.0, ID Screen Besnoitia indirect IDVET), two IFATs and seven Western blot tests (tachyzoite and bradyzoite extracts under reducing and non-reducing conditions). Two different definitions of a gold standard were used: (i) the result of the majority of tests ('Majority of tests') and (ii) the majority of test results plus pre-test information based on clinical signs ('Majority of tests plus pre-test info'). Relative to the gold standard 'Majority of tests', almost 100% sensitivity (Se) and specificity (Sp) were obtained with SALUVET-Madrid and FLI-Wusterhausen tachyzoite- and bradyzoite-based Western blot tests under non-reducing conditions. On the ELISAs, PrioCHECK Besnoitia Ab V2.0 showed 100% Se and 98.8% Sp, whereas ID Screen Besnoitia indirect IDVET showed 97.2% Se and 100% Sp. The in-house ELISA and INGEZIM BES 12.BES.K1 INGENASA showed 97.3% and 97.2% Se; and 94.6% and 93.0% Sp, respectively. IFAT FLI-Wusterhausen performed better than IFAT SALUVET-Madrid, with 100% Se and 95.4% Sp. Relative to the gold standard 'Majority of test plus pre-test info', Sp significantly decreased; this result was expected because of the existence of seronegative animals with clinical signs. All ELISAs performed very well and could be used in epidemiological studies; however, Western blot tests performed better and could be employed as a posteriori tests for control purposes in the case of uncertain results from valuable samples.Digital Object Identifier http://dx.doi.org/10.1111/j.1865-1682.2012.01318.x
机译:在欧洲,牛的贝氏病被认为是一种正在出现的慢性和衰弱性疾病。许多感染仍然是亚临床的,并且疾病的唯一迹象是巩膜和结膜中存在寄生性囊肿。血清学检测可用于检测无症状的牛/亚临床感染,以进行控制,因为目前尚无有效的药物或疫苗。为此,诊断工具需要进一步标准化。因此,本研究的目的是在一项多中心研究中比较欧洲现有的血清学检测方法。所有参与者(SALUVET-Madrid,FLI-Wusterhausen,ENV-Toulouse,IPB-Berne)提供了由感染和未感染的牛组成的241个特征明确的血清编码面板。评估的测试如下:一个内部ELISA,三个商业ELISA(INGEZIM BES 12.BES.K1 INGENASA,PrioCHECK Besnoitia Ab V2.0,ID Screen Besnoitia间接IDVET),两个IFAT和七个Western blot测试(速殖子和在还原和非还原条件下的缓殖子提取物。金标准使用了两种不同的定义:(i)大多数测试的结果(“多数测试”)和(ii)大多数测试结果以及基于临床体征的预测试信息(“多数测试”加上测试前信息”)。相对于金标准的“多数测试”,在非还原条件下,使用SALUVET-Madrid和FLI-Wusterhausen的基于速殖子和缓殖子的Western印迹试验可获得近100%的灵敏度(Se)和特异性(Sp)。在ELISA中,PrioCHECK贝氏痴呆抗体V2.0显示出100%的硒和98.8%的Sp,而ID筛查贝氏失调间接IDVET显示的是97.2%的硒和100%的Sp。内部ELISA和INGEZIM BES 12.BES.K1 INGENASA的Se含量为97.3%和97.2%;和94.6%和93.0%Sp。 IFAT FLI-Wusterhausen的表现优于IFAT SALUVET-Madrid,具有100%的硒和95.4%的Sp。相对于黄金标准“多数测试加上测试前信息”,Sp显着下降;由于存在具有临床体征的血清阴性动物,因此可以预期该结果。所有ELISA的表现都非常好,可用于流行病学研究。但是,在有价值样品的结果不确定的情况下,蛋白质印迹测试的效果更好,可以用作后验测试,以进行控制。Digital Object Identifier http://dx.doi.org/10.1111/j.1865-1682.2012.01318 。X

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号